KRAS and kidney cancer: Interestingly, while KRAS in RCC is understudied to date, AKT is a much more popular study area (18 publications with KRAS or K-ras in Title versus 168 publications with AKT in Title from over 42,000 kidney cancer publications as of March 21, 2021).